Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Cystinosis is a rare genetic disorder characterized by the accumulation of cystine crystals in different tissues and organs causing, among other symptoms, severe ocular manifestations. Cysteamine eye drops are prepared in hospital pharmacy departments to facilitate access to treatment, for which veh...
Saved in:
Main Authors: | Ana Castro-Balado (Author), Enrique Bandín-Vilar (Author), Andrea Cuartero-Martínez (Author), Laura García-Quintanilla (Author), Gonzalo Hermelo-Vidal (Author), Xurxo García-Otero (Author), Lorena Rodríguez-Martínez (Author), Jesús Mateos (Author), Manuela Hernández-Blanco (Author), Pablo Aguiar (Author), Irene Zarra-Ferro (Author), Miguel González-Barcia (Author), Cristina Mondelo-García (Author), Francisco J. Otero-Espinar (Author), Anxo Fernández-Ferreiro (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
by: Ana Castro-Balado, et al.
Published: (2023) -
Recent Research in Ocular Cystinosis: Drug Delivery Systems, Cysteamine Detection Methods and Future Perspectives
by: Ana Castro-Balado, et al.
Published: (2020) -
Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis
by: Anxo Fernández-Ferreiro, et al.
Published: (2017) -
Erratum found in «Farmacia Hospitalaria. 2020;44(4):149-57»
by: Ana Castro-Balado, et al.
Published: (2021) -
Ocular Biodistribution Studies using Molecular Imaging
by: Ana Castro-Balado, et al.
Published: (2019)